Download available for users with full-size access enabled
Vimovo - stay with
New Vimovo - the only prescription-strength NSAID therapy with a built-in PPI for OA pain relief patients can stay with Compared with EC-naproxen-controlled studies did not extend beyond 6 months
Take part of the Vimovo experience
Scan the tag above to start now or visit www.VIMOVOtouchpoints.com to learn more
Brand name: Vimovo Company: AstraZeneca Country/Market: USA, North America Target: Healthcare Professionals (HCP) Medium: Print ad Size/duration: Single-page Publication/Aired: Drug Topics - September 2010 Brand files